Filter by: Subject

Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.

Filter by: Subject

Results Per Page:

Patients (11)
Pharmacology (11)
Children (10)
Hepatotoxicity (9)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (9)
Anti-inflammatory (8)
Antioxidant (8)
Apoptosis (8)
Hypertension (8)
In vitro (8)
Malaria (8)
Pharmacokinetics (8)
Alzheimer’s disease (7)
Antidepressants (7)
Cancer (7)
Oxidative stress (7)
Acetylcholinesterase (6)
Africa (6)
Antimicrobial (6)
Pharmacists (6)
Plasmodium falciparum (6)
Potassium humate (6)
Safety (6)
Type 2 diabetes mellitus (T2DM) (6)
Wound healing (6)
Antibacterial (5)
Antimicrobial stewardship programmes (ASPs) (5)
Cardiovascular disease (5)
Efficacy (5)
Gastro-oesophageal reflux disease (GORD) (5)
Glutathione (5)
Hospitals (5)
Human endogenous retrovirus (HERV) (5)
Inflammation (5)
Knowledge (5)
Low- and middle-income countries (LMICs) (5)
Monoclonal antibody (MAb) (5)
Reactive oxygen species (ROS) (5)
Toxicity (5)
Traditional medicine (5)
Aloe ferox (4)
Aloe vera (4)
Anti-inflammatory agents (4)
Antimicrobials (4)
Antioxidant activity (4)
Asthma (4)
Breast cancer (4)
Clinical trials (4)
Clofazimine (4)
Depression (4)
Dopamine (4)
Flavonoids (4)
Guidelines (4)
Health sciences articles SDG-03 (4)
HepG2 cells (4)
Herbal remedies (4)
Human immunodeficiency virus (HIV) (4)
Humic acid (4)
Insomnia (4)
LC-MS/MS (4)
Pain (4)
Paracetamol (4)
Pseudomonas aeruginosa (4)
Spheroids (4)
Students (4)
Trastuzumab (4)
Acute upper respiratory tract infection (3)
Alcohol (3)
Allergic rhinitis (3)
Amaryllidaceae (3)
Anaemia (3)
Antibacterial agents (3)
Anticancer (3)
Anticoagulant (3)
Antidepressant (3)
Antimicrobial stewardship programs (3)
Antiretroviral (ARV) (3)
Attitudes (3)
AWaRe classification (3)
Benzodiazepines (3)
Blood-brain barrier (3)
Burkea africana (3)
Cardio-protection (3)
Cell culture (3)
Chemotherapy (3)
Clinical trial (3)
Early intervention (3)
Editorial (3)
Endogenous retrovirus (3)
Evidence-based Pharmacy Practice (3)
Free State Province, South Africa (3)
Fulvic acid (3)
HepG2 (3)
Hybrid compounds (3)
Liver (3)
Mitochondria (3)
Mitochondrial membrane potential (3)
Multiple sclerosis (MS) (3)
Noradrenaline (3)
Parkinson’s disease (PD) (3)